Treatment of Collagen gene related diseases by inhibition of natural antisense transcript to a collagen gene
Abstract:
The present invention relates to antisense oligonucleotides that modulate the expression of and/or function of a Collagen gene, in particular, by targeting natural antisense polynucleotides of a Collagen gene. The invention also relates to the identification of these antisense oligonucleotides and their use in treating diseases and disorders associated with the expression of Collagen genes.
Information query
Patent Agency Ranking
0/0